HLA-DRB and HLA-DQ Genetic Variability in Patients with Aspirin-Exacerbated Respiratory Disease

Author:

Esmaeilzadeh Hossein12,Nabavi Mohammad1,Amirzargar Ali Akbar3,Aryan Zahra45,Arshi Saba1,Bemanian Mohammad Hassan1,Fallahpour Morteza1,Mortazavi Negar6,Rezaei Nima4

Affiliation:

1. Department of Allergy and Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran

2. Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3. Molecular Immunology Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

5. Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran

6. Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background Major histocompatibility complex (MHC) class II is involved in T-cell activation, cytokine secretion, and induction of immune responses. Cytokines, staphylococcus super antigens, and eosinophil activation are proposed to play important roles in aspirin-exacerbated respiratory disease (AERD). Objectives This study is aimed at investigating the association of HLA-DRB and DQ genetic variabilities in patients with AERD. Methods A genetic association analysis in three different groups, including 33 patients with AERD, 17 patients with aspirin-tolerant asthma (ATA), and 100 healthy controls was performed. Oral aspirin challenge (OAC) test was performed to identify aspirin hypersensitivity. Pulmonary function test (PFT) was performed for all patients. Eosinophil percentage in nasal smear and peripheral blood and serum immunoglobin (Ig)E were investigated. HLA-DRB, HLA-DQA1, and HLA-DQB1 were genotyped using polymerase chain reaction. Results HLA-DQB1*0302 (OR, 5.49, 95% confidence interval [CI],(2.40-12.59)), HLA-DQA1*0301 (OR, 2.90, 95%CI,(1.49-5.67)), HLA-DRB4 (OR, 2.94, 95%CI,(1.61-5.36)), and HLA-DRB1*04 (OR, 3.19, 95%CI,(1.57-6.47)) were higher in patients with AERD compared with controls. In patients with AERD, HLA-DQB1*0301 (OR,0.22, 95%CI,(0.09-0.54)), HLA-DQA1*0501 (OR, 0.42, 95%CI, (0.21-0.81)), HLA-DRB1*11 (OR, 0.30, 95%CI,(0.12-0.73)), and HLA-DRB3 (OR, 0.38, 95%CI,(0.21-0.70)) were significantly lower compared with healthy controls. Patients with AERD had lower frequencies of HLA-DQB1*0301 (OR, 0.27, 95%CI,(0.08-0.86)), and HLA-DRB1*011 (OR, 0.27, 95%CI,(0.08-0.86)) compared with ATA. Haplotypes of HLA-DRB1*04/DQA1*0301/DQB1*0302 (OR, 4.25, 95%CI,(1.94-9.29)) and HLA-DRB1*07 /DQA1*0201/ DQB1*0201 (OR, 3.52, 95%CI,(1.54-8.06)) were higher in patients with AERD compared with controls (all p < 0.05). Conclusions Results of this study suggest that HLA-DQB1*0302 and HLA-DRB1*04 and their related haplotypes are genes involved in predisposing patients to AERD, whereas HLA-DQB1*0301 and HLA-DRB1*011 have negative association with AERD.

Publisher

SAGE Publications

Subject

General Medicine,Otorhinolaryngology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3